Pulmonary abnormalities in patients intravenously receiving the methanol extraction residue (MER) of Bacillus Calmette-Guerin

J. R. Quesada, H. I. Libshitz, Evan M Hersh, J. U. Gutterman

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Eight of 64 patients receiving intravenous administration of methanol extraction residue (MER) of Bacillus Calmette-Guerin (BCG), developed miliary-type pulmonary parenchymal changes. The clinical and radiological characteristics are described. An increased incidence was noted in patients with a history of previous BCG exposure or with positive PPD skin reactivity. Spontaneous resolution was observed upon discontinuation of MER. These changes most likely represent a granulomatous inflammatory process, although no histological confirmation was obtained.

Original languageEnglish (US)
Pages (from-to)1340-1343
Number of pages4
JournalCancer
Volume45
Issue number6
StatePublished - 1980
Externally publishedYes

Fingerprint

Mycobacterium bovis
Methanol
Lung
Tuberculin
Intravenous Administration
Skin
Incidence

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Pulmonary abnormalities in patients intravenously receiving the methanol extraction residue (MER) of Bacillus Calmette-Guerin. / Quesada, J. R.; Libshitz, H. I.; Hersh, Evan M; Gutterman, J. U.

In: Cancer, Vol. 45, No. 6, 1980, p. 1340-1343.

Research output: Contribution to journalArticle

Quesada, J. R. ; Libshitz, H. I. ; Hersh, Evan M ; Gutterman, J. U. / Pulmonary abnormalities in patients intravenously receiving the methanol extraction residue (MER) of Bacillus Calmette-Guerin. In: Cancer. 1980 ; Vol. 45, No. 6. pp. 1340-1343.
@article{10a477e2708b4e9ba9d80cd7cc8d89c7,
title = "Pulmonary abnormalities in patients intravenously receiving the methanol extraction residue (MER) of Bacillus Calmette-Guerin",
abstract = "Eight of 64 patients receiving intravenous administration of methanol extraction residue (MER) of Bacillus Calmette-Guerin (BCG), developed miliary-type pulmonary parenchymal changes. The clinical and radiological characteristics are described. An increased incidence was noted in patients with a history of previous BCG exposure or with positive PPD skin reactivity. Spontaneous resolution was observed upon discontinuation of MER. These changes most likely represent a granulomatous inflammatory process, although no histological confirmation was obtained.",
author = "Quesada, {J. R.} and Libshitz, {H. I.} and Hersh, {Evan M} and Gutterman, {J. U.}",
year = "1980",
language = "English (US)",
volume = "45",
pages = "1340--1343",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "6",

}

TY - JOUR

T1 - Pulmonary abnormalities in patients intravenously receiving the methanol extraction residue (MER) of Bacillus Calmette-Guerin

AU - Quesada, J. R.

AU - Libshitz, H. I.

AU - Hersh, Evan M

AU - Gutterman, J. U.

PY - 1980

Y1 - 1980

N2 - Eight of 64 patients receiving intravenous administration of methanol extraction residue (MER) of Bacillus Calmette-Guerin (BCG), developed miliary-type pulmonary parenchymal changes. The clinical and radiological characteristics are described. An increased incidence was noted in patients with a history of previous BCG exposure or with positive PPD skin reactivity. Spontaneous resolution was observed upon discontinuation of MER. These changes most likely represent a granulomatous inflammatory process, although no histological confirmation was obtained.

AB - Eight of 64 patients receiving intravenous administration of methanol extraction residue (MER) of Bacillus Calmette-Guerin (BCG), developed miliary-type pulmonary parenchymal changes. The clinical and radiological characteristics are described. An increased incidence was noted in patients with a history of previous BCG exposure or with positive PPD skin reactivity. Spontaneous resolution was observed upon discontinuation of MER. These changes most likely represent a granulomatous inflammatory process, although no histological confirmation was obtained.

UR - http://www.scopus.com/inward/record.url?scp=0018891304&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018891304&partnerID=8YFLogxK

M3 - Article

C2 - 7357523

AN - SCOPUS:0018891304

VL - 45

SP - 1340

EP - 1343

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 6

ER -